BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site

REFERENCES

• Abel, K. J., J. Xu, G. Y. Yin, R. H. Lyons, M. H. Meisler, and J. Weber 1995. Mouse Brca1: localization, sequence analysis and identification of evolutionarily conserved domains. Hum. Mol. Genet. 4:2265–2273.
   PubMed Web of Science ®Google Scholar
• Adams, P. D., W. R. Sellers, S. K. Sharma, A. D. Wu, C. M. Nalin, W. G. Kaelin Jr.. 1996. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16:6623–6633.
   PubMed Web of Science ®Google Scholar
• Anderson, S. F., B. P. Schlegel, T. Nakajima, E. S. Wolpin, and J. Parvin 1998. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat. Genet. 19:254–256.
   PubMed Web of Science ®Google Scholar
• Beijersbergen, R. L., and J. Bernards 1996. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta 1287:103–120.
   PubMed Web of Science ®Google Scholar
• Bennett, L. M., H. A. Brownlee, S. Hagevik, A. Haugen-Strano, and J. Wiseman 1996. Evolutionarily conserved domains of the rat BRCA1 protein. Proc. Annu. Meet. Am. Assoc. Cancer Res. 37:514–515.
   Google Scholar
• Bork, P., K. Hofmann, P. Bucher, A. F. Neuwald, S. F. Altschul, and J. Koonin 1997. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11:68–76.
   PubMed Web of Science ®Google Scholar
• Boyle, W. J., P. van der Geer, and J. Hunter 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110–149.
   PubMed Web of Science ®Google Scholar
• Breast cancer information core. 12 March 1999, revision date.www.nhgri.nih.gov/Intramural_research/Lab_transfer/bic/. [Online.] [5 May 1999, last date accessed.]
   Google Scholar
• Burke, T. F., K. S. Cocke, S. J. Lemke, E. Angleton, G. W. Becker, and J. Beckmann 1998. Identification of a BRCA1-associated kinase with potential biological relevance. Oncogene 16:1031–1040.
   PubMedGoogle Scholar
• Callebaut, I., and J. Mornon 1997. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400:25–30.
   PubMed Web of Science ®Google Scholar
• Chapman, M. S., and J. Verma 1996. Transcriptional activation by BRCA1. Nature 382:678–679.
   PubMedGoogle Scholar
• Chen, C. F., S. Li, Y. Chen, P. L. Chen, Z. D. Sharp, and J. Lee 1996. The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J. Biol. Chem. 271:32863–32868.
   PubMed Web of Science ®Google Scholar
• Chen, J., D. P. Silver, D. Walpita, S. B. Cantor, A. F. Gazdar, G. Tomlinson, F. J. Couch, B. L. Weber, T. Ashley, D. M. Livingston, and J. Scully 1998. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2:317–328.
   PubMed Web of Science ®Google Scholar
• Chen, Y., C. F. Chen, D. J. Riley, D. C. Allred, P. L. Chen, D. Von Hoff, C. K. Osborne, and J. Lee 1995. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270:789–791.
   PubMed Web of Science ®Google Scholar
• Chen, Y., P.-L. Chen, D. J. Riley, W.-H. Lee, D. C. Allred, and J. Osborne 1996. Location of BRCA1 in human breast and ovarian cancer cells. Science 272:125–126.
   PubMedGoogle Scholar
• Chen, Y., A. A. Farmer, C. F. Chen, D. C. Jones, P. L. Chen, and J. Lee 1996. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56:3168–3172.
   PubMed Web of Science ®Google Scholar
• Claus, E., N. Risch, and J. Thompson 1991. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet. 48:232–242.
   PubMed Web of Science ®Google Scholar
• Easton, D. F., D. T. Bishop, D. Ford, G. P. Crockford The Breast Cancer Linkage Consortium. 1993. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet. 52:678–701.
   PubMed Web of Science ®Google Scholar
• Fisher, R. P. 1997. CDKs and cyclins in transition(s). Curr. Opin. Genet. Dev. 7:32–38.
   PubMedGoogle Scholar
• Futreal, P. A., Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L. M. Bennett, A. Haugen-Strano, J. Swensen, Y. Miki et al.. 1994. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120–122.
   PubMed Web of Science ®Google Scholar
• Garcia-Patino, E., B. Gomendio, M. Provencio, J. M. Silva, J. M. Garcia, P. Espana, and J. Bonilla 1998. Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations. J. Clin. Oncol. 16:115–120.
   PubMedGoogle Scholar
• Gottlieb, T. M., and J. Oren 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287:77–102.
   PubMed Web of Science ®Google Scholar
• Gowen, L. C., A. V. Avrutskaya, A. M. Latour, B. H. Koller, and J. Leadon 1998. BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281:1009–1012.
   PubMed Web of Science ®Google Scholar
• Gowen, L. C., B. L. Johnson, A. M. Latour, K. K. Sulik, and J. Koller 1996. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12:191–194.
   PubMed Web of Science ®Google Scholar
• Greenman, J., S. Mohammed, D. Ellis, S. Watts, G. Scott, L. Izatt, D. Barnes, E. Solomon, S. Hodgson, and J. Mathew 1998. Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer. Genes Chromosomes Cancer 21:244–249.
   PubMedGoogle Scholar
• Grifman, M., and M. Weitzman (The Salk Institute). Unpublished data.
   Google Scholar
• Gudas, J. M., T. Li, H. Nguyen, D. Jensen, F. J. Rauscher III, and J. Cowan 1996. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ. 7:717–723.
   PubMedGoogle Scholar
• Hakem, R., J. L. de la Pompa, C. Sirard, R. Mo, M. Woo, A. Hakem, A. Wakeham, J. Potter, A. Reitmair, F. Billia, E. Firpo, C. C. Hui, J. Roberts, J. Rossant, and J. Mak 1996. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85:1009–1023.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., and J. Elledge 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:56–64.
   PubMed Web of Science ®Google Scholar
• Hunter, T., and J. Pines 1994. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573–582.
   PubMed Web of Science ®Google Scholar
• Jiang, W. Unpublished data.
   Google Scholar
• Jiang, W., G. Jimenez, N. J. Wells, T. J. Hope, G. M. Wahl, T. Hunter, and J. Fukunaga 1998. PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol. Cell 2:877–885.
   PubMed Web of Science ®Google Scholar
• Kanemitsu, M. Y., W. Jiang, and J. Eckhart 1998. Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ. 9:13–21.
   PubMedGoogle Scholar
• Kelsell, D. P., D. M. Black, D. T. Bishop, and J. Spurr 1993. Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. Hum. Mol. Genet. 2:1823–1828.
   PubMedGoogle Scholar
• Kelsell, D. P., N. K. Spurr, D. M. Barnes, B. Gusterson, and J. Bishop 1996. Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Lancet 347:1554–1555.
   PubMedGoogle Scholar
• Kerangueven, F., F. Eisinger, T. Noguchi, F. Allione, V. Wargniez, C. Eng, G. Padberg, C. Theillet, J. Jacquemier, M. Longy, H. Sobol, and J. Birnbaum 1997. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 14:339–347.
   PubMedGoogle Scholar
• Kinzler, K. W., and J. Vogelstein 1997. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386:761–763.
   PubMed Web of Science ®Google Scholar
• Koonin, E. V., S. F. Altschul, and J. Bork 1996. BRCA1 protein products... functional motifs... Nat. Genet. 13:266–268.
   PubMed Web of Science ®Google Scholar
• Lane, T. F., C. Deng, A. Elson, M. S. Lyu, C. A. Kozak, and J. Leder 1995. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev. 9:2712–2722.
   PubMed Web of Science ®Google Scholar
• Langston, A. A., K. E. Malone, J. D. Thompson, J. R. Daling, and J. Ostrander 1996. BRCA1 mutations in a population-based sample of young women with breast cancer. N. Engl. J. Med. 334:137–142.
   PubMed Web of Science ®Google Scholar
• Lees, E. 1995. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol. 7:773–780.
   PubMed Web of Science ®Google Scholar
• Lewin, B. 1990. Driving the cell cycle: M phase kinase, its partners, and substrates. Cell 61:743–752.
   PubMed Web of Science ®Google Scholar
• Liu, C. Y., A. Flesken-Nikitin, S. Li, Y. Zeng, and J. Lee 1996. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10:1835–1843.
   PubMed Web of Science ®Google Scholar
• Marquis, S. T., J. V. Rajan, A. Wynshaw-Boris, J. Xu, G. Y. Yin, K. J. Abel, B. L. Weber, and J. Chodosh 1995. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat. Genet. 11:17–26.
   PubMed Web of Science ®Google Scholar
• Meijer, L. 1996. Chemical inhibitors of cyclin-dependent kinases. Trends Cell Biol. 6:393–397.
   PubMed Web of Science ®Google Scholar
• Merajver, S. D., T. M. Pham, R. F. Caduff, M. Chen, E. L. Poy, K. A. Cooney, B. L. Weber, F. S. Collins, C. Johnston, and J. Frank 1995. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat. Genet. 9:439–443.
   PubMed Web of Science ®Google Scholar
• Miki, Y., J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, W. Ding et al.. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71.
   PubMed Web of Science ®Google Scholar
• Monteiro, A. N., A. August, and J. Hanafusa 1996. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA 93:13595–13599.
   PubMed Web of Science ®Google Scholar
• Neuhausen, S. L., and J. Marshall 1994. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res. 54:6069–6072.
   PubMed Web of Science ®Google Scholar
• Nigg, E. A. 1993. Cellular substrates of p34cdc2 and its companion cyclin-dependent kinases. Trends Cell Biol. 3:296–301.
   PubMedGoogle Scholar
• Nigg, E. A. 1995. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17:471–480.
   PubMed Web of Science ®Google Scholar
• Norbury, C., and J. Nurse 1992. Animal cell cycles and their control. Annu. Rev. Biochem. 61:441–470.
   PubMed Web of Science ®Google Scholar
• Orend, G., T. Hunter, and J. Ruoslahti 1998. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene 16:2575–2583.
   PubMedGoogle Scholar
• Ouchi, T., A. N. Monteiro, A. August, S. A. Aaronson, and J. Hanafusa 1998. BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. USA 95:2302–2306.
   PubMed Web of Science ®Google Scholar
• Ozcelik, H., M. D. To, J. Couture, S. B. Bull, and J. Andrulis 1998. Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int. J. Cancer 77:1–6.
   PubMedGoogle Scholar
• Pao, G., R. Janknecht, H. Ruffner, T. Hunter, and I. M. Verma. CBP/p300 interact functionally with BRCA1 as transcriptional co-activators. Submitted for publication.
   Google Scholar
• Papa, S., D. Seripa, G. Merla, C. Gravina, M. Giai, P. Sismondi, M. Rinaldi, A. Serra, G. Saglio, and J. Fazio 1998. Identification of a possible somatic BRCA1 mutation affecting translation efficiency in an early-onset sporadic breast cancer patient. J. Natl. Cancer Inst. 90:1011–1012.
   PubMedGoogle Scholar
• Pines, J. 1993. Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem. Sci. 18:195–197.
   PubMed Web of Science ®Google Scholar
• Ruffner, H., and J. Verma 1997. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl. Acad. Sci. USA 94:7138–7143.
   PubMed Web of Science ®Google Scholar
• Ruffner, H. Unpublished data.
   Google Scholar
• Schulman, B. A., D. L. Lindstrom, and J. Harlow 1998. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc. Natl. Acad. Sci. USA 95:10453–10458.
   PubMed Web of Science ®Google Scholar
• Scully, R., S. F. Anderson, D. M. Chao, W. Wei, L. Ye, R. A. Young, D. M. Livingston, and J. Parvin 1997. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA 94:5605–5610.
   PubMed Web of Science ®Google Scholar
• Scully, R., J. Chen, R. L. Ochs, K. Keegan, M. Hoekstra, J. Feunteun, and J. Livingston 1997. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90:425–435.
   PubMed Web of Science ®Google Scholar
• Scully, R., J. Chen, A. Plug, Y. Xiao, D. Weaver, J. Feunteun, T. Ashley, and J. Livingston 1997. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265–275.
   PubMed Web of Science ®Google Scholar
• Scully, R., S. Ganesan, M. Brown, J. A. De Caprio, S. A. Cannistra, J. Feunteun, S. Schnitt, and J. Livingston 1996. Location of BRCA1 in human breast and ovarian cancer cells. Science 272:123–125.
   PubMed Web of Science ®Google Scholar
• Shao, N., Y. L. Chai, E. Shyam, P. Reddy, and J. Rao 1996. Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13:1–7.
   PubMed Web of Science ®Google Scholar
• Somasundaram, K., H. Zhang, Y. X. Zeng, Y. Houvras, Y. Peng, G. S. Wu, J. D. Licht, B. L. Weber, and J. El-Deiry 1997. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389:187–190.
   PubMed Web of Science ®Google Scholar
• Somia, N. Unpublished data.
   Google Scholar
• Sourvinos, G., and J. Spandidos 1998. Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem. Biophys. Res. Commun. 245:75–80.
   PubMedGoogle Scholar
• Szabo, C. I., L. A. Wagner, L. V. Francisco, J. C. Roach, R. Argonza, M. C. King, and J. Ostrander 1996. Human, canine and murine BRCA1 genes: sequence comparison among species. Hum. Mol. Genet. 5:1289–1298.
   PubMedGoogle Scholar
• Thakur, S., H. B. Zhang, Y. Peng, H. Le, B. Carroll, T. Ward, J. Yao, L. M. Farid, F. J. Couch, R. B. Wilson, and J. Weber 1997. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17:444–452.
   PubMed Web of Science ®Google Scholar
• Thomas, J. E., M. Smith, B. Rubinfeld, M. Gutowski, R. P. Beckmann, and J. Polakis 1996. Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1. J. Biol. Chem. 271:28630–28635.
   PubMed Web of Science ®Google Scholar
• Thomas, J. E., M. Smith, J. L. Tonkinson, B. Rubinfeld, and J. Polakis 1997. Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ. 8:801–809.
   PubMedGoogle Scholar
• Thompson, M. E., R. A. Jensen, P. S. Obermiller, D. L. Page, and J. Holt 1995. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet. 9:444–450.
   PubMed Web of Science ®Google Scholar
• van den Heuvel, S., and J. Harlow 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050–2054.
   PubMed Web of Science ®Google Scholar
• van der Geer, P., K. Luo, B. M. Sefton, T. Hunter 1994. Phosphopeptide mapping and phosphoamino acid analysis on cellulose thin-layer plates, p. 422–448. In J. E. Celis (ed.), Cell biology: a laboratory handbook. Academic Press, New York, N.Y.
   Google Scholar
• Vaughn, J. P., P. L. Davis, M. D. Jarboe, G. Huper, A. C. Evans, R. W. Wiseman, A. Berchuck, J. D. Iglehart, P. A. Futreal, and J. Marks 1996. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ. 7:711–715.
   PubMedGoogle Scholar
• Wang, H., N. Shao, Q. M. Ding, J. Cui, E. S. Reddy, and J. Rao 1997. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15:143–157.
   PubMed Web of Science ®Google Scholar
• Wigler, M., A. Pellicer, S. Silverstein, R. Axel, G. Urlaub, and J. Chasin 1979. DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc. Natl. Acad. Sci. USA 76:1373–1376.
   PubMed Web of Science ®Google Scholar
• Wilson, C. A., M. N. Payton, G. S. Elliott, F. W. Buaas, E. E. Cajulis, D. Grosshans, L. Ramos, D. M. Reese, D. J. Slamon, and J. Calzone 1997. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. Oncogene 14:1–16.
   PubMed Web of Science ®Google Scholar
• Wilson, C. A., L. Ramos, M. R. Villasenor, K. H. Anders, M. F. Press, K. Clarke, B. Karlan, J. J. Chen, R. Scully, D. Livingston, R. H. Zuch, M. H. Kanter, S. Cohen, F. J. Calzone, and J. Slamon 1999. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat. Genet. 21:236–240.
   PubMed Web of Science ®Google Scholar
• Zhang, H., K. Somasundaram, Y. Peng, H. Tian, D. Bi, B. L. Weber, and J. El-Deiry 1998. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16:1713–1721.
   PubMed Web of Science ®Google Scholar
• Zhang, H. T., X. Zhang, H. Z. Zhao, Y. Kajino, B. L. Weber, J. G. Davis, Q. Wang, D. M. O’Rourke, H. B. Zhang, K. Kajino, and J. Greene 1997. Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene 14:2863–2869.
   PubMedGoogle Scholar